{"ok":true,"article":{"slug":"protagonist-therapeutics-strong-buy-icotyde-fda-approval-and-pn-881-advancement--31cfce43","title":"Protagonist Therapeutics: 'Strong Buy' ICOTYDE FDA Approval And PN-881 Advancement (PTGX)","url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOdUZTZmxpbkJvWWt1NFpmanFtZHN3QWRUYW9zc01QWHQ4V25jeGtueVFybENQNmhRdlc2SVRMQUtrQ3RiOG5ZVEhKZ3cwY1hmOEktRnlyR0I3aFE3Vk1WRW1CQlJGTVNQdVRTZVYwLWFVcERUQzZTZlNHWF9xSHdmb2ZWbGg3Vl9mMkR3elI5cDdfUndKa2p1UXlrdWFQdVBVbVI5YUpvMERXVU9RM3RpR2ltWVBpNm5fRTFzQQ?oc=5&hl=en-US&gl=US&ceid=US:en","canonical":"https://www.aimode.news/article/protagonist-therapeutics-strong-buy-icotyde-fda-approval-and-pn-881-advancement--31cfce43","sourceName":"Seeking Alpha","summary":"Related coverage: Protagonist Therapeutics: 'Strong Buy' ICOTYDE FDA Approval And PN-881 Advancement (PTGX) Seeking Alpha","category":"Health","image":null,"lang":"en","publishedAt":"2026-08-12T11:35:35+00:00","createdAt":"2026-08-12T13:30:12.6142+00:00"}}